Send to

Choose Destination
Surg Technol Int. 2018 Jun 1;32:61-66.

Practical Application of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients with Wounds.

Author information

Division of Wound Healing and Regenerative Medicine, Department of Surgery, Newark Beth Israel Medical Center, Newark, NJ.
NYU Winthrop Hospital, Mineola, NY.
Perioperative and Procedural Services, NYU Winthrop Hospital, Mineola, NY.
Division of Regenerative Medicine, NYU Winthrop Hospital, Mineola, NY.


Rapidly evolving advances in wound-care technologies and treatment modalities, including locally injectable granulocyte-macrophage colony-stimulating factor (GM-CSF), are increasingly being used. Based on its role in the stimulation and recruitment of key contributors to wound healing, such as keratinocytes, macrophages, and fibroblasts, GM-CSF is considered to play an essential role in the wound-healing cascade. Synthetic GM-CSF has been shown to have a positive effect on the healing of chronic wounds when given as a local injection in a small number of patients. Subsequent randomized, controlled trials demonstrated that GM-CSF accelerated the healing of chronic wounds. This paper reviews the proposed mechanism of action of GM-CSF in wound healing. We also describe its method of application in the operating room at a tertiary care center for patients with wounds. Key Messages: Many types of chronic wounds have an altered keratinocyte and macrophage function that can be potentially assuaged by the addition of locally injected growth factor therapy to standard-of-care treatment. Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been shown to be beneficial for the treatment of chronic, non-healing wounds. This article reviews the data on GM-CSF, reports a proposed mechanism of action, and describes its use by a team of wound surgeons.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Universal Medical Press
Loading ...
Support Center